Aclaris Therapeutics, Inc.
ACRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001557746
No open-market purchases or sales by Aclaris Therapeutics, Inc. insiders were filed in the last 90 days; 148 institutions reported holding it in 13F filings for Q2 2026, worth $630.0M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Aclaris Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 149
- +21 vs. Q4 2022
- Shares held
- 71.6M
- +5.77M (+8.8%) vs. Q4 2022
- Total value
- $579.3M
- −$457.0M (−44.1%) vs. Q4 2022
- New holders
- 41
- 43 more added
- Sold out
- 20
- 40 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 148 | $630.0M |
| Q1 2026 | 136 | $409.4M |
| Q4 2025 | 122 | $252.1M |
| Q3 2025 | 103 | $162.8M |
| Q2 2025 | 96 | $130.4M |
| Q1 2025 | 109 | $143.8M |
| Q4 2024 | 98 | $217.0M |
| Q3 2024 | 81 | $58.5M |
| Q2 2024 | 98 | $58.1M |
| Q1 2024 | 98 | $67.5M |
| Q4 2023 | 107 | $61.4M |
| Q3 2023 | 138 | $480.0M |
| Q2 2023 | 133 | $737.2M |
| Q1 2023 | 149 | $579.3M |
| Q4 2022 | 128 | $1.04B |
| Q3 2022 | 127 | $1.00B |
| Q2 2022 | 115 | $883.3M |
| Q1 2022 | 110 | $1.02B |
| Q4 2021 | 133 | $814.9M |
| Q3 2021 | 126 | $1.02B |
| Q2 2021 | 128 | $983.4M |
| Q1 2021 | 97 | $1.14B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Aclaris Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HighVista Strategies LLC | 197,803 | $1.60M | 1.30% | +10,184+5.4% | Added |
| Silverarc Capital Management, LLC | 220,100 | $1.78M | 0.80% | −132,093−37.5% | Reduced |
| Caption Management, LLC | 221,104 | $1.79M | 0.38% | +221,104 | New |
| Integral Health Asset Management, LLC | 225,000 | $1.82M | 0.38% | −145,000−39.2% | Reduced |
| Woodline Partners LP | 226,202 | $1.83M | 0.03% | −376,317−62.5% | Reduced |
| Bank of New York Mellon Corp | 230,270 | $1.86M | 0.00% | −1,343−0.6% | Reduced |
| Soleus Capital Management, L.P. | 249,000 | $2.01M | 0.25% | +249,000 | New |
| Frazier Life Sciences Management, L.P. | 264,377 | $2.14M | 0.15% | −25,812−8.9% | Reduced |
| Goldman Sachs Group Inc | 296,642 | $2.40M | 0.00% | −50,656−14.6% | Reduced |
| Ikarian Capital, LLC | 300,163 | $2.43M | 1.01% | +300,163 | New |
| Charles Schwab Investment Management Inc | 410,220 | $3.32M | 0.00% | −1,913−0.5% | Reduced |
| Jefferies Financial Group Inc. | 416,551 | $3.37M | 0.07% | +416,551 | New |
| Ghost Tree Capital, LLC | 425,000 | $3.44M | 1.30% | +425,000 | New |
| Assenagon Asset Management S.A. | 425,828 | $3.44M | 0.01% | +230,905+118.5% | Added |
| JPMorgan Chase & Co | 429,167 | $3.47M | 0.00% | +1,507+0.4% | Added |
| Aisling Capital Management LP | 434,455 | $3.51M | 1.69% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 529,839 | $4.29M | 0.84% | −615,100−53.7% | Reduced |
| Northern Trust Corp | 564,943 | $4.57M | 0.00% | −2,526−0.4% | Reduced |
| Schonfeld Strategic Advisors LLC | 570,243 | $4.61M | 0.04% | +158,005+38.3% | Added |
| Octagon Capital Advisors LP | 577,000 | $4.67M | 0.67% | +577,000 | New |
| Verition Fund Management LLC | 613,452 | $4.96M | 0.08% | +207,884+51.3% | Added |
| Commodore Capital LP | 635,000 | $5.14M | 0.78% | −1,245,286−66.2% | Reduced |
| Morgan Stanley | 676,618 | $5.47M | 0.00% | +536,214+381.9% | Added |
| Laurion Capital Management LP | 686,533 | $5.55M | 0.25% | −515,268−42.9% | Reduced |
| Samsara BioCapital, LLC | 696,171 | $5.63M | 1.16% | 00.0% | Unchanged |
| FMR LLC | 753,041 | $6.09M | 0.00% | −19,435−2.5% | Reduced |
| Vivo Capital, LLC | 898,631 | $7.27M | 0.54% | 00.0% | Unchanged |
| VR Adviser, LLC | 1,040,754 | $8.42M | 1.64% | −3,523,208−77.2% | Reduced |
| Samlyn Capital, LLC | 1,051,568 | $8.51M | 0.16% | +1,051,568 | New |
| Deutsche Bank AG | 1,102,197 | $8.92M | 0.00% | −75,396−6.4% | Reduced |
| Geode Capital Management, LLC | 1,114,572 | $9.02M | 0.00% | +55,824+5.3% | Added |
| Adage Capital Partners GP, L.L.C. | 1,180,000 | $9.55M | 0.02% | +480,000+68.6% | Added |
| Great Point Partners LLC | 1,191,581 | $9.64M | 1.91% | +172,299+16.9% | Added |
| Renaissance Technologies LLC | 1,252,152 | $10.1M | 0.01% | +130,400+11.6% | Added |
| Foresite Capital Management V, LLC | 1,258,243 | $10.2M | 7.52% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 1,344,600 | $10.9M | 0.04% | −438,000−24.6% | Reduced |
| State Street Corp | 1,423,354 | $11.5M | 0.00% | +120,024+9.2% | Added |
| Holocene Advisors, LP | 1,485,056 | $12.0M | 0.06% | −178,619−10.7% | Reduced |
| Deep Track Capital, LP | 1,708,971 | $13.8M | 0.59% | +1,708,971 | New |
| Foresite Capital Management IV, LLC | 2,808,034 | $22.7M | 11.79% | 00.0% | Unchanged |
| Citadel Advisors LLC | 3,107,764 | $25.1M | 0.03% | +2,032,724+189.1% | Added |
| Vanguard Group Inc | 3,192,426 | $25.8M | 0.00% | +70,171+2.2% | Added |
| Braidwell LP | 3,269,094 | $26.4M | 0.87% | +875,109+36.6% | Added |
| BVF Inc | 3,360,941 | $27.2M | 0.99% | +84,398+2.6% | Added |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $27.5M | 3.44% | +3,400,000 | New |
| Rock Springs Capital Management LP | 3,961,849 | $32.1M | 0.77% | +6000.0% | Added |
| Ra Capital Management, L.P. | 4,398,453 | $35.6M | 0.81% | 00.0% | Unchanged |
| BlackRock Inc. | 5,115,373 | $41.4M | 0.00% | +26,714+0.5% | Added |
| Wellington Management Group LLP | 7,372,601 | $59.6M | 0.01% | +1,888,588+34.4% | Added |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −2,758,434−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −341,239−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −65,307−100.0% | Sold out |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −50,964−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −45,535−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −22,009−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −21,800−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −20,503−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −16,350−100.0% | Sold out |
| X-Square Capital, LLC | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −15,093−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −14,753−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,423−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −8,800−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −5,533−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −4,788−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −1,124−100.0% | Sold out |
| Harbour Investments, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −208−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −16−100.0% | Sold out |